Presence of activating KRAS mutations correlates significantly with expression of tumour suppressor genes DCN and TPM1 in colorectal cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Presence of activating KRAS mutations correlates significantly with expression of tumour suppressor genes DCN and TPM1 in colorectal cancer ; volume:9 ; number:1 ; day:13 ; month:8 ; year:2009 ; pages:1-9 ; date:12.2009
BMC cancer ; 9, Heft 1 (13.8.2009), 1-9, 12.2009
- Creator
-
Mlakar, Vid
- Contributor
-
Berginc, Gašper
Volavšek, Metka
Štor, Zdravko
Rems, Miran
Glavač, Damjan
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-9-282
- URN
-
urn:nbn:de:1111-2016030352385
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mlakar, Vid
- Berginc, Gašper
- Volavšek, Metka
- Štor, Zdravko
- Rems, Miran
- Glavač, Damjan
- SpringerLink (Online service)
Other Objects (12)
S100PBP is regulated by mutated KRAS and plays a tumour suppressor role in pancreatic cancer
Understanding p53 tumour suppressor network
Understanding p53 tumour suppressor network
MiR-193a-3p is an Important Tumour Suppressor in Lung Cancer and Directly Targets KRAS
Regulation of the NF2 tumour suppressor Merlin
Degradation of tumour suppressor ρ53 during Chlamydia trachomatis infections
Computational identification of tumour suppressor protein p53 target genes
Degradation of Tumour Suppressor p53 during Chlamydia trachomatis Infections
Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity
The tumour suppressor p53 as a supporter of DNA replication
Expression analysis of candidate breast tumour suppressor genes on chromosome 16q
ZAR1 is a novel epigenetically inactivated tumour suppressor in lung cancer
S100PBP is regulated by mutated KRAS and plays a tumour suppressor role in pancreatic cancer
Understanding p53 tumour suppressor network
Understanding p53 tumour suppressor network
MiR-193a-3p is an Important Tumour Suppressor in Lung Cancer and Directly Targets KRAS
Regulation of the NF2 tumour suppressor Merlin
Degradation of tumour suppressor ρ53 during Chlamydia trachomatis infections
Computational identification of tumour suppressor protein p53 target genes
Degradation of Tumour Suppressor p53 during Chlamydia trachomatis Infections
Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity
The tumour suppressor p53 as a supporter of DNA replication
Expression analysis of candidate breast tumour suppressor genes on chromosome 16q
ZAR1 is a novel epigenetically inactivated tumour suppressor in lung cancer
S100PBP is regulated by mutated KRAS and plays a tumour suppressor role in pancreatic cancer
Understanding p53 tumour suppressor network
Understanding p53 tumour suppressor network
MiR-193a-3p is an Important Tumour Suppressor in Lung Cancer and Directly Targets KRAS
Regulation of the NF2 tumour suppressor Merlin
Degradation of tumour suppressor ρ53 during Chlamydia trachomatis infections
Computational identification of tumour suppressor protein p53 target genes
Degradation of Tumour Suppressor p53 during Chlamydia trachomatis Infections
Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity
The tumour suppressor p53 as a supporter of DNA replication
Expression analysis of candidate breast tumour suppressor genes on chromosome 16q